Sarah E. Emma
University of Wisconsin–Madison(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Nanoplatforms for cancer theranostics, Radiopharmaceutical Chemistry and Applications, Immunotherapy and Immune Responses, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy(2021)72 cited
- → Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy(2023)13 cited
- → Abstract 2255: Enhancing immunogenicity in immunologically cold ER+ breast cancer using estrogen receptor blockade and radiation therapy(2020)3 cited
- → Abstract 903: In vivo efficacy of bempegaldesleukin, immune checkpoint inhibition, and targeted radionuclide therapy in immunocompetent murine model of head and neck cancer(2020)1 cited
- → Abstract 676: Fulvestrant and radiation modify the tumor immune microenvironment in ER+ metastatic breast cancer and cooperate to enhance response to anti-PDL1 checkpoint blockade(2021)
- → Abstract 1304: Brachytherapy dose heterogeneity primes response to immune checkpoint blockade to generate anti-tumor immunity(2022)
- Design, synthesis, and evaluation of molecular inhibitors for biologically relevant enzymes(2013)
- → Abstract 902: Augmentation of anti-melanoma response by combining radiation-based in situ vaccination with GIFT4 B cell therapy(2020)
- → PP13 Presentation Time: 3:30 PM(2021)
- 90Y-NM600 Immunomodulates the Tumor Microenvironment of a Syngeneic Murine Model of Head and Neck Cancer to Improve Response to Bempegaldesleukin (NKTR-214) and Immune Checkpoint Inhibition(2020)